Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.4M Buy
16,537
+4,408
+36% +$609K 0.03% 84
2026
Q2
$1.56M Buy
12,129
+1,776
+17% +$208K 0.02% 97
2026
Q1
$1.25M Buy
10,353
+3,645
+54% +$421K 0.02% 91
2025
Q4
$717K Buy
6,708
+742
+12% +$69.7K 0.01% 123
2025
Q3
$501K Buy
5,966
+934
+19% +$76.9K 0.01% 118
2025
Q2
$393K Buy
5,032
+397
+9% +$31.6K 0.01% 108
2025
Q1
$384K Buy
4,635
+1,474
+47% +$138K 0.01% 95
2024
Q4
$276K Buy
3,161
+745
+31% +$76.8K 0.01% 115
2024
Q3
$246K Sell
2,416
-127
-5% -$15.1K 0.01% 123
2024
Q2
$293K Buy
+2,543
New +$328K 0.01% 109
2024
Q1
– Sell
-1,694
Closed -$215K – 128
2023
Q4
$215K Buy
+1,694
New +$176K 0.01% 106

Other funds holding MRK

Facet Wealth's MRK Position: Q3 2026 in Review

Facet Wealth increased its Merck (MRK) stake by 36% in Q3 2026, buying an estimated $609K and bringing the position to 16,537 shares worth $2.4M. The position accounts for 0.03% of the portfolio, ranked #84.

Facet Wealth first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Facet Wealth held 16,537 shares of Merck worth $2.4M as of Q3 2026.
  • Facet Wealth bought 4,408 Merck shares in Q3 2026, an estimated $609K.
  • Merck made up 0.03% of Facet Wealth's portfolio in Q3 2026, its #84 holding.
  • Facet Wealth first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.